Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Kosan concludes epothilone agreement with Roche and reveals clinical plans for KOS-1584

Nov. 7, 2007

GSK launches Atriance for treatment of lymph cancer

Nov. 6, 2007

MedImmune and Seattle Genetics further their antibody-drug conjugate collaboration

Nov. 6, 2007

ArQule initiates two phase II trials of ARQ-197

Nov. 6, 2007

Ipsen and Debiopharm extend their commercialization agreement for Decapeptyl

Nov. 6, 2007

Oxaliplatin formulation MBP-426 well tolerated in phase I study

Nov. 6, 2007

Nereus Pharmaceuticals' NPI-0052, NPI-2358 assessed in phase I cancer studies

Nov. 6, 2007

New data on oblimersen pharmacokinetics, in vivo activity reported

Nov. 6, 2007

Enzon initiates phase I study of EZN-2968 to evaluate additional dosing schedule

Nov. 5, 2007

MGCD-0103 and gemcitabine given in combination to patients with solid tumors

Nov. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...